ArticleGenetics and molecular biology2023

In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts.

Fernanda Sperb-Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.